Large-scale genetic testing can measure many DNA variants at once, but a broad scan does not automatically predict whether you will develop a common disease. The result depends on what the test measures and how the findings are interpreted. For common, multifactorial diseases, a polygenic risk score (PRS) estimates risk; it is not a diagnosis, and it must be considered alongside factors such as family history and clinical screening guidance.
What does “large-scale gene scanning” mean?
It describes a family of approaches that examine many genetic variants in one test. Next-generation sequencing (NGS) is a measurement technology: it can sequence large sections of a person’s genome. Whole-exome sequencing (WES) focuses on the exome, while whole-genome sequencing (WGS) examines the genome more broadly. A disease-specific panel targets a selected set of genes or variants. These approaches differ in what they measure; none, by itself, guarantees a meaningful prediction of common-disease risk. The U.S. Food and Drug Administration describes NGS as an advance that can rapidly sequence large sections of a genome in clinical precision medicine (FDA, “Precision Medicine”).
As an Amazon Associate I earn from qualifying purchases.
A PRS is different: it is an interpretation method, not a sequencing technology. It combines information from many variants to estimate a person’s relative or overall likelihood of a particular outcome, according to the score’s design. A scan may provide genetic data that could be used in an analysis, but the score and its evidence determine what the result can reasonably say.
The Tool Desk
Outbyte PC Repair FREERepair Windows errors before they cause bigger problemsFix Now →Outbyte Driver Updater FREEScan for outdated or missing drivers - takes under a minuteDriver Scan →How do sequencing and risk interpretation differ?
| Approach | What it does | What it does not establish by itself |
|---|---|---|
| WGS or WES | Sequences broad portions of DNA; WGS covers the genome more broadly, while WES focuses on the exome. | That every measured variant is clinically meaningful, or that the test provides a validated common-disease prediction. |
| Disease-specific genetic panel | Examines selected genes or variants relevant to a defined question. | Risk outside the selected targets, or a comprehensive picture of common-disease risk. |
| Polygenic risk score | Uses many variants to produce a statistical estimate for a particular disease or outcome. | A diagnosis, certainty about an individual’s future, or a guarantee that using the score improves health. |
The distinctions matter because “more variants” is not the same as “more useful.” FDA guidance on NGS-based in-vitro diagnostics addresses analytical validation—whether a test reliably detects what it claims to measure—but accurate measurement alone does not prove that a score predicts disease well or changes care for the better (FDA, April 2018).
#1 Best Overall
- TOP-SELLING CONSUMER DNA TEST: From your origins in over 3,600 places around the world to the most connections to living relatives, no other DNA test kit delivers an experience as unique and interactive as AncestryDNA.
- YOUR DATA, YOUR CONTROL: We give you full control over your genetic information. You decide what to share, and with whom.
- A FEW SIMPLE STEPS: Simply activate your DNA kit online and return your saliva sample in the prepaid package to our state-of-the-art lab. Your results will be available online in roughly six weeks.
- ORIGINS AND INHERITANCE: AncestryDNA provides more precise ancestral origins with greater geographic detail. Our innovative SideView technology takes your results even further by showing your origins and matches by parental side. *Some DNA features require an Ancestry subscription.
- BUILD YOUR FAMILY TREE: Combine what you learn from your DNA results with an Ancestry subscription and gain access to millions of family trees and the world's largest collection of online family history records. *Access to record collections varies depending on subscription level.
What can a result say about a common disease?
Common diseases usually arise through a mix of genetic and non-genetic influences. A PRS can indicate that someone’s estimated genetic risk is higher or lower than a reference or comparison group, depending on the particular score and how it is reported. It cannot say with certainty whether that person will develop the disease. The American College of Medical Genetics and Genomics (ACMG) describes PRS results as statistical predictions of increased clinical risk, not diagnoses. A low score does not rule out significant risk (ACMG, 2023).
Population fit also matters. A score developed or validated in a population unlike the person receiving it may have poor predictive value for them. Do not assume a score performs equally across ancestry groups unless there is evidence for that score in the relevant population. No single accuracy figure applies to all broad genetic scans: performance depends on the named test or score, disease, population, and intended use.
Rank #2
- REVIEW IMPORTANT TEST INFO: There is a lot to consider with genetic testing. Before purchasing, review important information about Genetic Health Risk* and Carrier Status* reports at 23andme. org/test-info. A portion of your purchase may be eligible for FSA/HSA reimbursement***.
- UNDERSTAND YOUR GENETIC HEALTH: Get 10+ Condition reports* that show whether you have genetic variants associated with a higher risk of certain conditions. Includes FDA-authorized reports, and you choose whether to view certain reports.
- PLAN AHEAD WITH 45+ CARRIER STATUS REPORTS*: Discover if you carry a genetic variant for inherited conditions across categories like blood, lung, and hearing health, information you can bring to family planning conversations with your healthcare provider.
- OPTIMIZE YOUR DAILY WELLNESS: See how your genes may influence lifestyle factors like deep sleep, lactose intolerance, genetic weight, and muscle composition.
- MAP YOUR ORIGINS ACROSS 5,000+ REGIONS: Explore your Ancestry Composition, trace maternal and paternal haplogroups (paternal requires a Y chromosome), and dig into your Neanderthal Ancestry. Opt in to find up to 1,500 DNA Relatives, and your Family Tree builds itself automatically.
How to judge whether a test is meaningful
Four separate questions help distinguish a technically impressive scan from a clinically useful one. The FDA and the National Human Genome Research Institute (NHGRI) discuss test validation and evidence; ACMG’s population-screening guidance also emphasizes whether screening connects people to beneficial care.
- Analytical validity: Does the laboratory detect the variants it claims to measure accurately and reliably? This is a question about the assay and laboratory performance, not whether a detected variant predicts disease.
- Clinical validity: Does the variant or score predict the specific disease or outcome claimed, for the population and use case in question? NHGRI’s report highlights the importance of association evidence, replication, and testing in a representative population (NHGRI, “Promoting Safe and Effective Genetic Testing in the United States”). A statistically significant association does not by itself show that a variant causes disease: a common polymorphism may be associated with increased risk without being necessary or sufficient for the disease.
- Clinical utility: Does acting on the result help someone make a better decision about diagnosis, treatment, management, or prevention? A valid prediction does not automatically demonstrate that using it improves health outcomes (USPSTF technical brief, 2021).
- Ethical, legal, and social implications: How will consent, privacy, family implications, access, and equity be handled? These are part of the ACCE framework described in the USPSTF technical brief.
Screening is not the same as diagnostic testing
Screening may be offered to people without a specific prior reason to suspect a disease. Diagnostic testing is generally prompted by symptoms, family history, or other evidence that raises the likelihood of a condition. A risk result from screening should not be treated as a diagnosis or substituted for an appropriate clinical evaluation. ACMG says population-screening programs can benefit people only when risk identification is linked to evidence-based risk-reducing care (ACMG, 2021).
Rank #3
- REVIEW IMPORTANT TEST INFO: There is a lot to consider with genetic testing. Before purchasing, review important information about Genetic Health Risk*, Carrier Status*, and Pharmacogenetics** reports at 23andme. org/test-info and 23andme. org/test-info/pharmacogenetics. A portion of your purchase may be eligible for FSA/HSA reimbursement***.
- UNDERSTAND YOUR GENETIC HEALTH: Receive 160+ personalized genetic reports, including 50+ Conditions* and wellness reports. Get insights into heart health, metabolic health, mental health, and more. You choose whether to view certain reports.
- TRACK HEALTH GOALS: Health Tracks(SM) show how everyday choices may shape your health over time. Opt in to the Family Health History Tree to input and track information to share with your healthcare provider.
- PLAN AHEAD WITH 45+ CARRIER STATUS REPORTS*: Find out whether you carry a genetic variant for inherited conditions across categories like blood, lung, and hearing health, information you can bring to family planning conversations with your healthcare provider.
- LEARN HOW YOUR BODY MAY RESPOND: FDA-authorized pharmacogenetics reports show how your DNA may impact the way your body processes certain medications**, including some used in heart health and mental health care. Talk to your healthcare provider before making any medication changes.
Broad scans can reveal other kinds of findings
Exome or genome testing may also identify possible monogenic disease risks, carrier status, or pharmacogenomic findings—information about how genes may affect responses to medicines. These are distinct from polygenic risk estimates for common disease. They have different evidence standards and care pathways, so a finding in one category should not be interpreted as if it were another. ACMG’s guidance on elective exome and genome testing discusses these possible categories (ACMG, 2021).
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.Questions to ask before acting on a result
- What exactly was measured: WGS, WES, a targeted panel, or a PRS based on existing data?
- Which disease and outcome does the result address, and what evidence supports that use?
- Has the score been evaluated in a population relevant to me?
- What would change in my care because of this result, and is that change supported by evidence?
- How should the result be considered alongside my family history, age, health history, and established screening recommendations?
- What consent, privacy, family, and follow-up interpretation arrangements apply?
ACMG advises that genetic risk results be interpreted in context rather than used alone (ACMG, 2023; ACMG, 2021). A clinician can help determine whether a finding calls for follow-up; a genetic counselor may also be relevant when the result, family implications, or testing choices need explanation.
Quick Recap
Best Value
- The Most Accurate Breed Detection: Screen for 430+ breeds— to get a breed report down to 1%. Because knowing every detail helps you understand how to care for them
- Unlock 30 Essential Health Insights: Screen for genetic health tests (including MDR1 and IVDD) to get ahead of health risks and create a personalized care plan with your vet
- Meet Their Relatives: 99.9% of dogs tested have a relative match through Wisdom Panel. With the world’s largest breed database and 5 million dogs tested, you can see photos, compare DNA results, and send messages
- Learn About Their Traits and Behaviors: Know them better inside and out. Wisdom Panel screens for 51 traits so you can learn how their one of a kind appearance came to be. Plus, understand their individual quirks with insights into 3 unique behavioral tendencies
- 5m+ Pets Tested In 60+ Countries: Wisdom Panel is the world’s leading dog DNA service thanks to its quick, painless swabbing process, fast and accurate results, and reliable insights you can use for years to come
Rank #4
- ABOUT THE TEST: The Genetrace DNA Paternity Test helps families conclusively determine if a man is the true father of a child.
- NO HIDDEN FEES: Kit includes all lab fees and sample return costs to test one (1) child and one (1) potential father.
- FAST RESULTS: Get secure, confidential results within 1-2 business days after testing begins. We'll keep you updated every step of the way.
- EASY SAMPLE COLLECTION: No needles, no blood, no doctors. Collect your samples with our easy-to-use mouth swabs, then return them to the lab with the provided prepaid return envelope. It's quick, easy & painless.
- ACCURATE & RELIABLE: Up to 27 genetic markers analyzed for over 99.999% accuracy. All tests performed TWICE in our AABB, ISO 17025 & CLIA accredited laboratory.
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
What’s actually slowing this PC down?
Pick the symptom - the matching free tool is one click away.
